| 注册
首页|期刊导航|医药导报|复方丹参滴丸治疗糖尿病视网膜病变的药效物质基础和作用机制研究进展

复方丹参滴丸治疗糖尿病视网膜病变的药效物质基础和作用机制研究进展

毛樱潞 郑颖 高艳华 安若凡 周强 杨维

医药导报2026,Vol.45Issue(4):617-624,8.
医药导报2026,Vol.45Issue(4):617-624,8.DOI:10.3870/j.issn.1004-0781.2026.04.009

复方丹参滴丸治疗糖尿病视网膜病变的药效物质基础和作用机制研究进展

Research Progress on the Pharmacodynamic Material Basis and Mechanisms of Compound Danshen Dripping Pills in the Treatment of Diabetic Retinopathy

毛樱潞 1郑颖 1高艳华 1安若凡 1周强 2杨维1

作者信息

  • 1. 中国中医科学院中药研究所道地药材品质保障与资源持续利用全国重点实验室,北京 100700
  • 2. 天士力医药集团股份有限公司,天津 300410
  • 折叠

摘要

Abstract

The pharmacological effects of compound Danshen dripping pills(CDDP)in the treatment of diabetic reti-nopathy(DR)are attributed to various bioactive constituents,including saponins,phenolic acids,and diterpene quinones.Re-searches indicate that CDDP exerts therapeutic effects against DR through multiple pathways,such as protecting vascular endothelial cells,inhibiting pathological neovascularization,improving hemorheology,regulating blood lipid levels,and promoting the repair of retinal microstructure.However,the precise mechanisms underlying its preventive and therapeutic actions in DR remain incom-pletely understood.This review provides an overview of recent advances in the pharmacodynamic material basis,pharmacological activities,and associated mechanisms of CDDP.It aims to offer a scientific foundation for the clinical application and further de-velopment of CDDP,as well as for the research and development of novel therapies for diabetic retinopathy.

关键词

复方丹参滴丸/糖尿病视网膜病变/药效物质基础/作用机制

Key words

Compound Danshen dripping pills/Diabetic retinopathy/Pharmacodynamic material basis/Mechanism of action

分类

医药卫生

引用本文复制引用

毛樱潞,郑颖,高艳华,安若凡,周强,杨维..复方丹参滴丸治疗糖尿病视网膜病变的药效物质基础和作用机制研究进展[J].医药导报,2026,45(4):617-624,8.

基金项目

四大慢病重大专项(2023ZD0509300) (2023ZD0509300)

中国中医科学院科技创新工程资助项目(CI2023E002) (CI2023E002)

中央级公益性科研院所基本科研业务费专项资金资助项目(ZXKT25014). (ZXKT25014)

医药导报

1004-0781

访问量5
|
下载量0
段落导航相关论文